Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat

References

• Hamilton J. B. Male hormone stimulation is prerequisite and an incitant in common baldness. Am. J. Anat. 1942; 71: 451
   Google Scholar
• Mowszowicz I., Riahi M., Wright F., Bouchard P. H., Kutten F., Mauvais-Jarvis P. Androgen receptors in human skin cytosol. J. Clin. Endocrinol. Metab. 1981; 52: 338
   PubMed Web of Science ®Google Scholar
• Voigt W., Fernandez E. P., Hsia S. L. Transformation of testosterone into 17β-hydroxy-5α-androstan-3-one by microsomal preparations of human skin. J. Biol. Chem. 1970; 245: 5595
   Google Scholar
• Hammerstein J., Cupceancu B. Behandlung des Hirsutismus mit Cyproteroneacetat. Dtsch Med. Wochenschr. 1969; 94: 829
   PubMed Web of Science ®Google Scholar
• Hammerstein J., Moltz L., Schwartz U. Antiandrogens in the treatment of acne and hirsutism. J. Steroid Biochem. 1983; 19: 591
   Google Scholar
• Boisselle A., Tremblay R. R. New therapeutic approach to the hirsute patient. Fertil. Steril. 1979; 32: 276
   Google Scholar
• Shapiro G., Evron S. A novel use of spironolactone: treatment of hirsutism. J. Clin. Endocrinol. Metab. 1980; 51: 429
   PubMed Web of Science ®Google Scholar
• Poyet P., Labrie F. Comparison of the antiandrogenic/androgenic activities of Flutamide, cyproterone acetate and megestrol acetate. Moll. Cell. Endocrinol. 1985; 42: 283
   PubMedGoogle Scholar
• Neri R., Florance K., Koziol P., van Cleave S. A biological profile of a nonsteroidal antiandrogen, SCH13521 (4′-nitro-3′-trifluoro-methylisobutyranilide). Endocrinology 1972; 91: 427
   PubMed Web of Science ®Google Scholar
• Plante M., Poyet P., Poulin R., Labrie F. Medroxyprogesterone acetate has androgenic but no antiandrogenic activity while spironolactone is a weak mixed agonist-antagonist. Anticancer Res., Int. J. Cancer Res. Treat. 1986; 6: 386
   Google Scholar
• Kagawa C. M. Blocking the renal electrolyte effects of mineralocorticoids with orally active steroidal spironolactone. Endocrinology 1960; 125: 125
   Google Scholar
• Hertz R., Tullner W. W. Progestational activity of certain steroids—spironolactones. Proc. Soc. Exp. Biol. Med. 1958; 99: 451
   Google Scholar
• Levy J., Burshell A., Marbach M., Ayllalo L., Glick J. M. Interaction of spironolactone with oestradiol receptors in cytosol. J. Endocrinol. 1980; 84: 371
   Google Scholar
• Dorfmann R. I. (1971) Androgens. Proceedings of the Third International Congress on Hormonal Steroids. 1971, V. James, L. Martini. Excerpta Medica, Amsterdam, 995
   Google Scholar
• Simard J., Luthy I., Guay J., Bélanger A., Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol. Cell. Endocrinol. 1986; 44: 261
   PubMed Web of Science ®Google Scholar
• Calandra R., Luthy I., Finocchiaro L., Cheb-Terrab R. Influence of sex and gonadectomy on sex steroid receptors in rat adrenal gland. J. Steroid Biochem. 1980; 13: 1331
   Google Scholar
• Thorell J. I., Johansson B. G. Enzymatic iodination of poly-peptides with 125I to high specific activity. Biochim. Biophys. Acta 1971; 251: 363
   PubMed Web of Science ®Google Scholar
• Tsuruhara T., Dufau M. L., Cigorraga S., Catt K. J. Hormonal regulation of testicular luteinizing hormone. J. Bid. Chem. 1977; 252: 9002
   PubMed Web of Science ®Google Scholar
• Kledzik G. S., Cusan L., Auclair C., Kelly P. A., Labrie F. Inhibitory effect of luteinizing hormone (LH)-releasing hormone agonist on rat ovarian LH and follicle-stimulating hormone receptor levels during pregnancy. Fertil. Steril. 1978; 29: 560
   Google Scholar
• Bélanger A., Caron S., Picard S. Simultaneous radioimmunoassay of progestins, ardrogens and estrogens in rat testis. J. Steroid Biochem. 1980; 13: 185
   PubMedGoogle Scholar
• Bélanger A., Cusan L., Caron S., Barden N., Dupont A. Ovarian progestins, androgens and estrogens throughout the 4-day estrous cycle in the rat. Biol. Reprod. 1900; 24: 591
   Google Scholar
• Carmichael R., Bélanger A., Cusan L., Séguin C., Caron S., Labrie F. Increased testicular androstane-3α-17β-diol formation induced by treatment with [D-Ser(TBU)6]-des-Gly-[NH210]LHRH ethylamide in the rat. Steroids 1980; 36: 383
   Google Scholar
• Pirke K. M. A radioimmunoassay for the measurement of 5-androsten-3β, 17β-diol in plasma. Steroids 1977; 30: 53
   Google Scholar
• MacKenna T. J., Dipietro D. B., Brown R. D., Strott C. A., Liddle G. W. Plasma 17-OH-pregnenolone in normal subjects. J. Clin. Endocrinol. Metab. 1974; 39: 933
   Google Scholar
• Lowry O. H., Clemens J. A., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265
   PubMed Web of Science ®Google Scholar
• Rodbard D., Lewald J. E. Computer analysis of radioligand assay. Second Karolinska Symposium on Research Methods in Reproductive Endocrinology, E. Diczfalusy. Bogtryklereit Forum, Copenhagen 1970; 79
   Google Scholar
• Bardin C. W., Lipsett M. B. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J. Clin. Invest. 1967; 46: 891
   PubMed Web of Science ®Google Scholar
• Kirschner M. A., Bardin C. W. Androgen production and metabolism in normal and virilized women. Metabolism 1972; 21: 667
   PubMed Web of Science ®Google Scholar
• Kuttenn D., Mowszowicz I., Schaison G., Mauvais-Jarvis P. Androgen production and skin metabolism in hirsutism. J. Endocrinol. 1977; 75: 83
   PubMed Web of Science ®Google Scholar
• Kuttenn F., Rigaud C., Wright F., Mauvais-Jarvis P. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol. J. Clin. Endocrinol. Metab. 1977; 51: 1107
   Google Scholar
• Biffignandi P., Massucchetti C., Molinatti M. Female hirsutism: pathological considerations and therapeutical implications. Endocrinol. Rev. 1984; 5: 498
   Google Scholar
• Mowszowicz I., Wright F., Vincens M., Rigaud C., Nahoul K., Mavier P., Guillemant S., Kutten F., Mauvais-Jarvis P. Androgen metabolism in hirsute patients treated with cyproterone acetate. J. Steroid Biochem. 1984; 20: 757
   PubMedGoogle Scholar
• Labrie F., Dupont A., Bélanger A. Complete androgen blockade for the treatment of prostate cancer. Important Advances in Oncology, V. T. De Vita, Jr, S. Hellman, S. A. Rosenberg. Lippincott, Philadelphia 1985; 193–217
   Google Scholar
• Labrie F., Pelletier G., Labrie R., Ho-Kim M. A., Delgado A., Mac Intosh B., Fortier C. Liaison transcortine-corticostérone et contrle de I'activité hypophyso-surrénalienne chez le rat. Interactions hypophyse-thyroïde-surrénales-gonades. Annales d'Endocrinologie (Paris) 1968; 29: 29
   Google Scholar